Pancreatitis, Ozempic and exaggerated headlines: A UK alert raises concerns about drug abuse

Pancreatitis, Ozempic and exaggerated headlines: A UK alert raises concerns about drug abuse

Last week, many media outlets reported on a press release from the UK Medicines and Healthcare products Regulatory Agency (MHRA). It sought the collaboration of people hospitalized with acute pancreatitis. The goal was to investigate whether the risk of pancreatic inflammation in people taking GLP-1 medicine for weight loss or type 2 diabetes, such as the popular drug Ozempic, could be genetically influenced. Alison Cave, head of safety at the M…